Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix

Aim:  Only limited data are available regarding mucin antigen expression in adenocarcinoma of the uterine cervix.

[1]  C. Morrison,et al.  The Mucin Expression Profile of Endometrial Carcinoma and Correlation With Clinical-Pathologic Parameters , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[2]  Guy Storme,et al.  Prognostic value of histopathology and trends in cervical cancer : a SEER population study , 2007 .

[3]  U. Manne,et al.  Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix. , 2006, Archives of pathology & laboratory medicine.

[4]  Wen‐hua Zhang,et al.  [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery]. , 2004, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[5]  N. Yaegashi,et al.  Mucin Expression in Nonneoplastic and Neoplastic Glandular Epithelia of the Uterine Cervix , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[6]  T. Irimura,et al.  Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma , 2003, Histopathology.

[7]  N. Sakuragi,et al.  Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy , 2002, Acta obstetricia et gynecologica Scandinavica.

[8]  M. Ghazizadeh,et al.  Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas. , 2002, Japanese journal of clinical oncology.

[9]  K. Imai,et al.  Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis , 2002, Pathology international.

[10]  K. Imai,et al.  New classification of pancreatic intraductal papillary–mucinous tumour by mucin expression: its relationship with potential for malignancy , 2002, The Journal of pathology.

[11]  T. O'brien,et al.  The CA 125 Gene: An Extracellular Superstructure Dominated by Repeat Sequences , 2001, Tumor Biology.

[12]  B. Yin,et al.  Molecular Cloning of the CA125 Ovarian Cancer Antigen , 2001, The Journal of Biological Chemistry.

[13]  T. Irimura,et al.  Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma , 1999, Hepatology.

[14]  T. Irimura,et al.  Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  S. Takao,et al.  MUC‐1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas , 1998, Pathology international.

[16]  S. Yonezawa,et al.  Expression of mucin antigens in human cancers and its relationship with malignancy potential , 1997, Pathology international.

[17]  Ho-Hsiung Lin,et al.  Risk Factors for Recurrence in Patients With Stage IB, IIA, and IIB Cervical Carcinoma After Radical Hysterectomy and Postoperative Pelvic Irradiation , 1996, Obstetrics and gynecology.

[18]  K. Imai,et al.  Effect of MUC1 Mucin, an Anti‐adhesion Molecule, on Tumor Cell Growth , 1996, Japanese journal of cancer research : Gann.

[19]  J. Wesseling,et al.  A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. , 1996, Molecular biology of the cell.

[20]  Ying-jv Lu,et al.  Prognostic factors of early stage cervical cancer treated by radical hysterectomy , 1995, Cancer.

[21]  A. Sonnenberg,et al.  Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components , 1995, The Journal of cell biology.

[22]  Y. Kim,et al.  Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. , 1994, Human pathology.

[23]  C. Melief,et al.  Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. , 1993, Journal of immunology.

[24]  M. Ligtenberg,et al.  Suppression of cellular aggregation by high levels of episialin. , 1992, Cancer research.

[25]  H Fox,et al.  Pathological prognostic indicators in cervical cancer with particular reference to patients under the age of 40 years , 1989, British journal of obstetrics and gynaecology.

[26]  T. Inoue,et al.  The prognostic significance of the minimum thickness of uninvolved cervix in patients with cervical carcinoma stages IB, IIA, and IIB. , 1986, Gynecologic oncology.

[27]  I. Gipson,et al.  MUC16 Is Lost from the Uterodome (Pinopode) Surface of the Receptive Human Endometrium: In Vitro Evidence That MUC16 Is a Barrier to Trophoblast Adherence1 , 2008, Biology of reproduction.

[28]  J. Voynow,et al.  Respiratory tract mucin genes and mucin glycoproteins in health and disease. , 2006, Physiological reviews.

[29]  H. Boussen,et al.  Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix. , 2006, American journal of obstetrics and gynecology.

[30]  A. Mitsuhashi,et al.  Correlation between MUC5AC expression and the prognosis of patients with adenocarcinoma of the uterine cervix , 2006, Annals of Surgical Oncology.

[31]  W. Hop,et al.  Prognostic factors in adenocarcinoma of the uterine cervix. , 2004, Gynecologic oncology.

[32]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[33]  諏訪 高麿.  Increased invasiveness of MUC1 cDNA-transfected human gastric cancer MKN74 cells , 1998 .